ADHD med shortages push DEA to up drug allotment by 23.5%
Ars Technica 2024-09-06
Summary:
The DEA's quota increase is for Vyvanse and its generic forms.
Link:
https://arstechnica.com/?p=2047969From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica